Co-Infection in COVID-19 Pneumonia: Discussion Continues
- PMID: 36596687
- PMCID: PMC9840957
- DOI: 10.3947/ic.2022.0110
Co-Infection in COVID-19 Pneumonia: Discussion Continues
Abstract
Sixty-six patients with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 and pneumonia on chest computer tomography were prospectively recruited. A combined respiratory swab for polymerase chain reaction (PCR), urine sample for pneumococcal and Legionella antigen, and sputum or endotracheal aspirate were collected. Urinary antigen and blood culture tests were negative in all cases as well as the PCR tests for other respiratory viruses and atypical bacterial pathogens. In total, 5 patients (7.5%) had co-infection. By PCR a high prevalence of colonization with bacterial pathogens was found. In conclusion, co-infection is rare in coronavirus disease 2019 patients, and additional examination to identify other pathogens should be performed only in selected cases.
Keywords: Antibiotics; COVID-19; Co-infection; Pneumonia; SARS-CoV-2.
Copyright © 2022 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS.
Conflict of interest statement
No conflict of interest.
References
-
- Johns Hopkins University & Medicine. Coronavirus resource center. COVID-19 Dashboard. [Accessed 10 July 2022]. Available at: https://coronavirus.jhu.edu/map.html.
-
- Vaughn VM, Gandhi TN, Petty LA, Patel PK, Prescott HC, Malani AN, Ratz D, McLaughlin E, Chopra V, Flanders SA. Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19): a multi-hospital cohort study. Clin Infect Dis. 2021;72:e533–e541. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous